MERGE (Model Ensemble for Ranking Genomic Effects) is an advanced platform aimed at improving the accuracy and reliability of genomic variant predictions. By combining multiple state-of-the-art AI models, MERGE provides a comprehensive solution for predicting the pathogenicity of missense variants.
Our mission is to harness the power of AI and machine learning to better understand the genetic factors influencing human health. By providing researchers and clinicians with accurate predictions, we hope to facilitate the discovery of new therapeutic targets and improve personalized medicine.
MERGE offers a variety of features, including:
The MERGE project is developed and maintained by a team of genomic researchers, AI specialists, and healthcare professionals. Our team works diligently to ensure that MERGE remains at the cutting edge of genomic variant prediction and analysis.